Home » MILLENNIUM ACHIEVES $10 MILLION MILESTONE PAYMENT
MILLENNIUM ACHIEVES $10 MILLION MILESTONE PAYMENT
Millennium Pharmaceuticals, Inc. today announced
the Company will receive a $10 million payment from Johnson & Johnson Pharmaceutical
Research & Development, L.L.C. (J&JPRD) based on sales milestones reached
for VELCADE (bortezomib) for Injection in territories outside the U.S. Milestone
payments are recorded in the strategic alliance revenue line on the Company's
income statement.
Yahoo
News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May